Angiotensin II human

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

血管紧张素 II 人通过血管紧张素转换酶 (ACE) 去除两个 C 末端残基而被血管紧张素 I 转化。

Angiotensin II human is converted by Angiotensin I through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE). Angiotensin II is mediated by AT1 and AT2 receptors, which are seven transmembrane glycoproteins with 30% sequence similarity.

——

——

Angiotensin II | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe

Endocrinology/Hormones

RAAS

AT receptor

Cardiovascular Disease

——

4474-91-3

1046.18

C50H71N13O12

>98% (HPLC)

H2O: ≥ 50 mg/mL

O=C(O)C[C@H](N)C(N[C@@H](CCC/N=C(N)\N)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CN=CN2)C(N3[C@H](C(N[C@H](C(O)=O)CC4=CC=CC=C4)=O)CCC3)=O)=O)=O)=O)=O)=O

(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid

(-20℃)

With Ice Pack

≥ 2 years